← All stocks

Vivani Medical, Inc.

VANI Net buying
CIK 0001266806 #4205 in the set updated 17 Sep 2026
Bought (120 mo)
$67.94M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$8.09M
$0.00 on a plan · $0.00 straight out of an exercise
Sold at will
$8.09M
28 of 28 sales
Net
+$59.85M
+$59.85M against sales at will

By person

21 insiders · 271 transactions
1.9×

Adam Mendelsohn holds only 1.9 times base salary in stock. $1.18M of shares against $610.00K in salary for 2025.

Salary from the company's own proxy. The shares are what Adam Mendelsohn last reported holding, valued at $1.26, the price Common Stock was last bought or sold at on the open market here, on 15 Jul 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Williams Gregg
Director
$67.59M (189)
+$67.59M
178,755,468
$225.23M
+159.6%
Alfred E. Mann Living Trust entity
10% owner
$7.94M (13)
−$7.94M
0
0.0000%
$0.00
−100.0%
Bolck Joachim Eberhard
10% owner
$239.22K (23)
+$239.22K
3,072,894
3.41%
$3.87M
+6.1%
McGuire Jonathan Will
Director
$73.81K (9)
−$73.81K
20,469
0.0227%
$25.79K
Dwyer Donald
Chief Business Officer
$63.23K (17)
+$63.23K
55,000
0.0610%
$69.30K
Randolph Edward David
Vice President Manufacturing
$51.93K (3)
−$51.93K
22
<0.0001%
$27.72
0.0%
Mendelsohn Aaron
Director
$37.58K (2)
+$37.58K
935,557
1.04%
$1.18M
OKLAND STEPHEN D
Chief Commercial Officer
$22.58K (2)
−$22.58K
23,641
0.0262%
$29.79K
0.0%
Makes Brigid
Chief Financial Officer
$14.88K (6)
+$14.88K
15,000
0.0166%
$18.90K
Greenberg Robert J.
Chairman of Board
$3.82K (1)
−$3.82K
172,911
0.1917%
$217.87K
−1.1%
LINK WILLIAM J PHD
Director
4,608,161
5.11%
$5.81M
+2.0%
Mendelsohn Adam
Chief Executive Officer
3,695,573
4.10%
$4.66M
Baker Wilford Dean
Director
197,482
0.2189%
$248.83K
PFEFFER MATTHEW J
Director
118,301
0.1311%
$149.06K
+577.5%
MILLER THOMAS B
Chief Financial Officer
78,354
0.0869%
$98.73K
+617.6%
Cosendai Gregoire
VP Clinical Affairs
23,484
0.0260%
$29.59K
+16.7%
RYAN WILLIAM PATRICK
Chief Operating Officer
2,261
0.0025%
$2.85K
Popoff Alexandra L.
Director
2,166
0.0024%
$2.73K
Blake John T
Chief Financial Officer
1,754
0.0019%
$2.21K
Dorn Jessy Dana
VP-Clin & Scientific Affairs
1,458
0.0016%
$1.84K
0.0%
Jacques David Murray
VP-Research Development
0
0.0000%
$0.00
Insider
Date
Role
Action
Shares
Price
Amount
McGuire Jonathan Will
8 Mar 2018
Chief Executive Officer
Exercised, kept
11,875
$1.73
$20.54K
Showing 250 of 271 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 304
Amendments (4/A) skipped 0
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 0
Sales at will 28
Transactions with no price 0
Shares from compensation/vesting 63,403,270
Sales filed before the plan box existed 28
History held since 22 Nov 2016